Bionomics Ltd (BNO.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 663 | 663 | 766 | 763 | N/A |
| Accounts receivable | 115 | 299 | 4,065 | -4,011 | N/A |
| Accounts payable and accrued liabilities | -918 | 804 | N/A | N/A | N/A |
| Other Working Capital | -364 | 1,455 | 4,612 | -3,854 | N/A |
| Other Operating Activity | 581 | -17,902 | -23,571 | -7,864 | 0 |
| Operating Cash Flow | $77 | $-14,681 | $-14,128 | $-14,966 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 0 | 119 | 26 |
| Purchase Of Investment | N/A | N/A | 0 | 0 | -89 |
| Sale Of Investment | N/A | N/A | 0 | 300 | N/A |
| Other Investing Activity | 0 | 0 | 317 | 9 | 3 |
| Investing Cash Flow | $N/A | $N/A | $317 | $428 | $-60 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -106 | -120 | -8,330 |
| Common Stock Issued | 1,528 | 10,112 | 4,911 | 22,626 | 32,936 |
| Other Financing Activity | 0 | 4,997 | -1,127 | -3,935 | -898 |
| Financing Cash Flow | $1,528 | $15,109 | $3,678 | $18,571 | $23,707 |
| Exchange Rate Effect | -4 | 77 | -5 | -548 | -10 |
| Beginning Cash Position | 12,687 | 12,182 | 22,218 | 19,605 | 3,439 |
| End Cash Position | 14,289 | 12,687 | 12,080 | 23,090 | 21,413 |
| Net Cash Flow | $1,606 | $428 | $-10,132 | $4,032 | $17,983 |
| Free Cash Flow | |||||
| Operating Cash Flow | 77 | -14,681 | -14,128 | -14,966 | N/A |
| Capital Expenditure | N/A | N/A | N/A | -1 | -1 |
| Free Cash Flow | 77 | -14,681 | -14,128 | -14,967 | -1 |